Orit Rozenberg

1.1k total citations
18 papers, 911 citations indexed

About

Orit Rozenberg is a scholar working on Clinical Biochemistry, Plant Science and Pharmacology. According to data from OpenAlex, Orit Rozenberg has authored 18 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 5 papers in Plant Science and 4 papers in Pharmacology. Recurrent topics in Orit Rozenberg's work include Paraoxonase enzyme and polymorphisms (6 papers), Cynara cardunculus studies (5 papers) and Apelin-related biomedical research (4 papers). Orit Rozenberg is often cited by papers focused on Paraoxonase enzyme and polymorphisms (6 papers), Cynara cardunculus studies (5 papers) and Apelin-related biomedical research (4 papers). Orit Rozenberg collaborates with scholars based in Israel and United States. Orit Rozenberg's co-authors include Michael Aviram, Diana M. Shih, Mira Barak, Amy B. Howell, Tony Hayek, Maayan Shiner, Daniel Golan, Sara Dishon, Idit Lavi and Elsebeth Staun-Ram and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Orit Rozenberg

18 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Orit Rozenberg Israel	11	508	324	199	145	129	18	911
Melahat Dirican Türkiye	18	279 0.5×	111 0.3×	74 0.4×	81 0.6×	177 1.4×	53	958
Majid Tavafi Iran	14	96 0.2×	134 0.4×	137 0.7×	43 0.3×	65 0.5×	38	947
Renzo Schiavon Italy	18	219 0.4×	98 0.3×	110 0.6×	89 0.6×	173 1.3×	40	815
R. Urgert Netherlands	12	119 0.2×	94 0.3×	682 3.4×	46 0.3×	151 1.2×	18	1.1k
Thomas M. van Himbergen Netherlands	14	249 0.5×	122 0.4×	112 0.6×	52 0.4×	47 0.4×	18	728
M. Rodo Poland	18	101 0.2×	221 0.7×	48 0.2×	56 0.4×	566 4.4×	40	954
Simona Masciangelo Italy	12	140 0.3×	57 0.2×	60 0.3×	38 0.3×	108 0.8×	14	493
Nurettin Aydoĝdu Türkiye	17	76 0.1×	46 0.1×	52 0.3×	60 0.4×	93 0.7×	46	773
Mungli Prakash India	12	96 0.2×	86 0.3×	40 0.2×	64 0.4×	77 0.6×	33	580
Maha A. Alamin Saudi Arabia	16	64 0.1×	70 0.2×	61 0.3×	41 0.3×	71 0.6×	30	709

Countries citing papers authored by Orit Rozenberg

Since Specialization

Citations

This map shows the geographic impact of Orit Rozenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Rozenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Rozenberg more than expected).

Fields of papers citing papers by Orit Rozenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orit Rozenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Rozenberg. The network helps show where Orit Rozenberg may publish in the future.

Co-authorship network of co-authors of Orit Rozenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Orit Rozenberg. A scholar is included among the top collaborators of Orit Rozenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orit Rozenberg. Orit Rozenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cohen, Idan, et al.. (2023). The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose. The Oncologist. 28(4). e225–e227. 8 indexed citations

Yefet, Enav, Shira Baram, Amir Weiss, et al.. (2022). Should pregnant women be screened for SARS‐CoV‐2 infection? A prospective multicenter cohort study. International Journal of Gynecology & Obstetrics. 160(1). 161–166. 1 indexed citations

Yefet, Enav, et al.. (2022). Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2: a prospective multicenter cohort study. Clinical Microbiology and Infection. 28(9). 1258–1262. 7 indexed citations

Gozlan, Yael, Itay Bar-Or, Emilia Anis, et al.. (2021). Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018. Eurosurveillance. 26(6). 6 indexed citations

Rozenberg, Orit, Firas Rinawi, Baruch Yerushalmi, et al.. (2020). Automated Analyzers Are Suited for Diagnosing Celiac Disease Without a Biopsy. Journal of Pediatric Gastroenterology and Nutrition. 71(1). 64–70. 4 indexed citations

Shiran, Avinoam, Basheer Karkabi, Eran Zittan, et al.. (2015). Association of Vitamin B12 Deficiency with Homozygosity of the TT MTHFR C677T Genotype, Hyperhomocysteinemia, and Endothelial Cell Dysfunction.. PubMed. 17(5). 288–92. 20 indexed citations

Froom, Paul, et al.. (2014). Triple positive antiphospholipid antibody profile in outpatients with tests for lupus anticoagulants. Clinical Chemistry and Laboratory Medicine (CCLM). 53(1). 53–6. 1 indexed citations

Golan, Daniel, Elsebeth Staun-Ram, Lea Glass‐Marmor, et al.. (2013). The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis. Brain Behavior and Immunity. 32. 180–185. 55 indexed citations

Froom, Paul, et al.. (2013). The association of serum antiphospholipid antibodies and dilute Russell's viper venom times. Journal of Clinical Pathology. 67(5). 441–444. 5 indexed citations

10.

Golan, Daniel, Lea Glass‐Marmor, Elsebeth Staun-Ram, et al.. (2013). Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties. BMC Neurology. 13(1). 60–60. 66 indexed citations

11.

Rozenberg, Orit, et al.. (2011). A Novel Algorithm for the Diagnosis of Celiac Disease and a Comprehensive Review of Celiac Disease Diagnostics. Clinical Reviews in Allergy & Immunology. 42(3). 331–341. 32 indexed citations

12.

Rozenberg, Orit, et al.. (2011). A new algorithm for the diagnosis of celiac disease. Cellular and Molecular Immunology. 8(2). 146–149. 22 indexed citations

13.

Rozenberg, Orit, Maayan Shiner, Michael Aviram, & Tony Hayek. (2008). Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties. Free Radical Biology and Medicine. 44(11). 1951–1959. 60 indexed citations

14.

Rozenberg, Orit & Michael Aviram. (2006). S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochemical and Biophysical Research Communications. 351(2). 492–498. 59 indexed citations

15.

Rozenberg, Orit, Diana M. Shih, & Michael Aviram. (2005). Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis. 181(1). 9–18. 127 indexed citations

16.

Rozenberg, Orit, Amy B. Howell, & Michael Aviram. (2005). Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. Atherosclerosis. 188(1). 68–76. 63 indexed citations

17.

Rozenberg, Orit. (2003). Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radical Biology and Medicine. 34(6). 774–784. 240 indexed citations

18.

Rozenberg, Orit, Diana M. Shih, & Michael Aviram. (2003). Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis. Arteriosclerosis Thrombosis and Vascular Biology. 23(3). 461–467. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact